Skip to main content


We're creating a new version of this page. See preview

Volume 9 Supplement 2

AIDS Vaccine 2012

  • Poster presentation
  • Open Access

Performance of self-reported adherence to oral pre-exposure prophylaxis (PrEP) among HIV heterosexual serodiscordant couples in rural Uganda

  • 1,
  • 1,
  • 1,
  • 1,
  • 1,
  • 2,
  • 3,
  • 4 and
  • 1
Retrovirology20129 (Suppl 2) :P213

  • Published:


  • Positive Predictive Value
  • Negative Predictive Value
  • Adherence Rate
  • Adherence Measure
  • Medical Event Monitoring System


Adherence is one of the main determinants of PrEP efficacy. Most PrEP studies applied subjective adherence measures, which often produce overestimates and problematic efficacy data interpretation; creating a need for more objective measures. This study examines self-reported adherence to oral PrEP compared to Medical Events Monitoring System (MEMS).


Seventy-two HIV-uninfected partners (50% women) in Uganda were randomized to daily or intermittent (Monday, Friday and within 2 hours after sex, not exceeding 1 dose/day) oral emtricitabine/tenofovir or placebo in a 2:1:2:1 ratio for four months. Adherence was assessed monthly by MEMS and self-reported taken or missed doses by timeline follow-back calendar. MEMS data was adjusted for extra openings without pill removal and removal of multiple pills. Non-fixed days within intermittent regimen were classified as adherent/non-adherent based on self-reported sex by SMS. Adherence rates by taken/missed doses were compared to raw MEMS data using Spearman correlation.


Treatment and placebo groups were combined since adherence rates were similar. Daily raw MEMS adherence rate was significantly higher than fixed Intermittent rate (p=0.04) and post-coital dosing rate (p<0.0001). Raw MEMS data for daily and fixed intermittent dosing, poorly correlated with self-reported taken doses (r=0.14, p=0.42 and r=0.01, p=0.94, respectively) and missed doses (r=0.30, p=0.08 and r=0.07, p=0.69, respectively). Self-reported daily adherence had high sensitivity but only fair positive predictive value (PPV) and very poor specificity. Self-reported adherence to intermittent fixed dosing had fair sensitivity, PPV and negative predictive value (NPV), but poor specificity. Self-reported adherence to post-coital dosing had very good sensitivity and NPV but poor specificity.


Median adherence for daily and intermittent fixed PrEP was high by objective and subjective measures, but poorly correlated. Adherence to post-coital dosing was poor and likely overestimated by self-report (possibly reflecting technical challenges of SMS). Self-reported adherence measures were highly sensitive but poorly specific.

Authors’ Affiliations

Medical Research Council/Uganda Virus Research Institute, Entebbe, Uganda
The EMMES Corporation, New York, NY, USA
International AIDS Vaccine Initiative, New York, USA
Massachusetts General Hospital Center for Global Health, Boston, MA, USA


© Kibengo et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.